Literature DB >> 16265041

Update on the etiology, pathogenesis and diagnosis of ulcerative colitis.

Stephen B Hanauer1.   

Abstract

Evidence is accumulating that both genetic and environmental factors contribute to ulcerative colitis. The most consistent genetic associations have been shown for the MHC locus HLA Class II alleles, but the interleukin-1 family of genes and the multidrug resistance gene MDR1 have also been implicated as genetic susceptibility factors for the development of disease. In addition, there is a relationship between ulcerative colitis and bacterial flora, with an increased number of adherent Bacteroides spp. and Enterobacteriaceae spp. present in inflamed bowel segments. Conversely, cigarette smoking and appendectomy have both been shown to protect against the development of ulcerative colitis. Despite our improved understanding of the genetics and inflammatory mechanisms that underpin this disease, however, the etiology and pathogenesis of ulcerative colitis remain undefined. The diagnosis of ulcerative colitis is being aided by recent advances in diagnostic strategies, including the detection of fecal and serologic markers and the use of wireless capsule endoscopy, but, in the absence of a pathognomonic marker, the definition of this disease remains based on well-established clinical, endoscopic and histologic criteria. In particular, it is difficult to discriminate ulcerative colitis from other forms of colitis, including Crohn's disease, and there seems to be a growing overlap of pathophysiologic processes between ulcerative colitis and post-infectious irritable bowel syndrome. Patients who remain indeterminate between ulcerative colitis and Crohn's disease also continue to be a diagnostic challenge.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16265041     DOI: 10.1038/ncpgasthep0031

Source DB:  PubMed          Journal:  Nat Clin Pract Gastroenterol Hepatol        ISSN: 1743-4378


  8 in total

Review 1.  Obesity and severe asthma.

Authors:  Hiroki Tashiro; Stephanie A Shore
Journal:  Allergol Int       Date:  2018-12-01       Impact factor: 5.836

2.  Colonic hypereosinophilia in ulcerative colitis may help to predict the failure of steroid therapy.

Authors:  Giuseppe Leoncini; Vincenzo Villanacci; Maria Grazia Marin; Valentina Crisafulli; Moris Cadei; Elisabetta Antonelli; Claudio Leoci; Gabrio Bassotti
Journal:  Tech Coloproctol       Date:  2018-12-10       Impact factor: 3.781

3.  Highlights from digestive disease week 2010.

Authors:  Edward V Loftus
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-08

4.  The potential role of a self-management intervention for ulcerative colitis: a brief report from the ulcerative colitis hypnotherapy trial.

Authors:  Laurie Keefer; Jennifer L Kiebles; Monika A Kwiatek; Olafur Palsson; Tiffany H Taft; Zoran Martinovich; Terrence A Barrett
Journal:  Biol Res Nurs       Date:  2011-02-28       Impact factor: 2.522

5.  Behavioral interventions may prolong remission in patients with inflammatory bowel disease.

Authors:  Laurie Keefer; Jennifer L Kiebles; Zoran Martinovich; Elyse Cohen; Alyssa Van Denburg; Terrence A Barrett
Journal:  Behav Res Ther       Date:  2010-12-30

Review 6.  Curcumin for maintenance of remission in ulcerative colitis.

Authors:  Sushil Kumar; Vineet Ahuja; Mari Jeeva Sankar; Atul Kumar; Alan C Moss
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17

7.  Turmeric-derived nanovesicles as novel nanobiologics for targeted therapy of ulcerative colitis.

Authors:  Caifang Gao; Yangyang Zhou; Zhejie Chen; Hongyi Li; Yaqin Xiao; Wei Hao; Ying Zhu; Chi Teng Vong; Mohamed A Farag; Yitao Wang; Shengpeng Wang
Journal:  Theranostics       Date:  2022-07-18       Impact factor: 11.600

8.  Probiotics combined with aminosalicylic acid affiliates remission of ulcerative colitis: a meta-analysis of randomized controlled trial.

Authors:  Lijun Peng; Yan Zhong; Aiping Wang; Zhisheng Jiang
Journal:  Biosci Rep       Date:  2019-01-18       Impact factor: 3.840

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.